Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBSYS for Acute Procedure-related Pain
NCT02138409Phase 3Withdrawn
- Sponsor
- Insys Therapeutics
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of fentanyl, sponsored by Insys Therapeutics. Planned start Dec 2017; status: withdrawn.
02
Drugs
fentanyl
Beyond the preview
Go deeper on NCT02138409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138409.